Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, JPT to Co-promote Array Products

NEW YORK (GenomeWeb News) – Tecan and JPT Peptide Technologies today announced a deal to co-promote JPT's catalog peptide arrays and profiling capabilities.

Under the terms of the agreement, the companies will co-promote JPT's products alongside Tecan's microarray handling devices. Other terms were not disclosed.

"Providing a high level of data quality and consistency is a burning need in microarray research," Siegfried Sasshofer, director of marketing detection at Tecan Austria, said in a statement. "Combining JPT peptide microarrays with our Tecan HS 4800 Pro and HS 400 Pro hybridization stations for automated microarray processing will provide our customers with a new level of process standardization to maximize the value of their research."

Tecan, based in Männedorf, Switzerland, provides laboratory instruments and solutions to the biopharmaceutical, forensics, and clinical diagnostics markets. Based in Berlin, JPT is a wholly owned subsidiary of BioNTech and provides services and tools for peptide-related projects.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.